About MEVAC
MEVAC is a company based in Cairo (Egypt) founded in 2007 was acquired by Kemin in April 2021. MEVAC offers products and services including Poultry Vaccines, Ruminants Vaccines, Aquaculture Vaccines, Equine Vaccines, and Rabbits Vaccines. MEVAC operates in a competitive market with competitors including Zoetis, Ceva, PetMedix, QBiotics and Bio-Sourcing, among others.
- Headquarter Cairo, Egypt
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Mevac For Vaccines
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MEVAC
MEVAC offers a comprehensive portfolio of products and services, including Poultry Vaccines, Ruminants Vaccines, Aquaculture Vaccines, Equine Vaccines, and Rabbits Vaccines.
Vaccines for protecting poultry from diseases like avian influenza
Vaccines for safeguarding ruminants against various health threats
Vaccines designed to protect fish in aquaculture settings
Vaccines for equine health and disease prevention
Vaccines to address rabbit health issues
Funding Insights of MEVAC
Detailed funding history for MEVAC
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in MEVAC
MEVAC has secured backing from 1 investor. Prominent investors backing the company include Kemin.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Animal feed additives and specialty food ingredients are developed.
|
Locked | Locked | Locked |
Investor details for MEVAC
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MEVAC
Investment portfolio details for MEVAC
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - MEVAC
Detailed financials for MEVAC
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Mevac Comparisons
Peer comparison for MEVAC
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MEVAC
MEVAC operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zoetis, Ceva, PetMedix, QBiotics and Bio-Sourcing, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Animal medicines, vaccines, and diagnostics are manufactured and supplied.
|
|
| Locked | Locked | Locked |
Animal health therapeutics are developed and supplied globally by Ceva.
|
|
| Locked | Locked | Locked |
Developer of monoclonal antibody therapeutics for pets
|
|
| Locked | Locked | Locked |
Small molecules from plant extracts are developed for medical applications.
|
|
| Locked | Locked | Locked |
Biopharmaceuticals for animals are manufactured and supplied through partnerships.
|
|
| Locked | Locked | Locked |
Manufacturer of animal vaccines and healthcare products
|
Detailed competitors of MEVAC
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Mevac
Complete news archive for MEVAC
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MEVAC
MEVAC was founded in 2007.
MEVAC is headquartered in Cairo, Egypt.
MEVAC was established in 2007 in Cairo, Egypt, within the veterinary biotechnology sector. Inactivated and live-attenuated vaccines are produced for poultry, rabbits, equine, ruminants, and aquatic species to address viral and bacterial infections. Additional services, including sample collection, diagnostic testing, and vaccination tools such as sprays and injectors, are offered to support animal health management in these areas.
MEVAC offers Poultry Vaccines, Ruminants Vaccines, Aquaculture Vaccines, Equine Vaccines, and Rabbits Vaccines.
MEVAC has 1 investor. Key investors include Kemin.